Record
Loading…
Record
Loading…
organization · fact
As of November 9, 2026, Gilead Sciences's quarterly revenue on the AsOf record is $8.3 billion, dated September 30, 2026, from a primary source (sec.gov).
AsOf. "Gilead Sciences quarterly revenue: 8,300,000,000 United States dollar", as of 2026-09-30. Claim clm_64E20B8C7E0A, https://asof.is/claim/clm_64E20B8C7E0A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209526000039/0000882095-26-000039-index.htm.
AsOf. (2026). Gilead Sciences quarterly revenue: 8,300,000,000 United States dollar (as of 2026-09-30) [Record clm_64E20B8C7E0A]. Retrieved November 9, 2026, from https://asof.is/claim/clm_64E20B8C7E0A (source: https://www.sec.gov/Archives/edgar/data/882095/000088209526000039/0000882095-26-000039-index.htm)
@misc{asof_clm_64E20B8C7E0A,
author = {AsOf},
title = {Gilead Sciences quarterly revenue: 8,300,000,000 United States dollar},
year = {2026},
howpublished = {\url{https://asof.is/claim/clm_64E20B8C7E0A}},
note = {Claim clm\_64E20B8C7E0A, as of 2026-09-30; source: https://www.sec.gov/Archives/edgar/data/882095/000088209526000039/0000882095-26-000039-index.htm},
urldate = {2026-11-09}
}